发明名称 NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF DISEASE
摘要 The present invention relates to compounds and methods which may be useful as treatments of diseases.
申请公布号 US2016375037(A1) 申请公布日期 2016.12.29
申请号 US201615197118 申请日期 2016.06.29
申请人 Reveragen Biopharma, Inc. 发明人 McCall John M.;Hoffman Eric;Nagaraju Kanneboyina;Damsker Jesse
分类号 A61K31/57 主分类号 A61K31/57
代理机构 代理人
主权项 1. A method of treating a disease selected from the group consisting of acute lymphocytic leukemia, Addison's disease, adrenal hyperplasia, adrenocortical insufficiency, allergic conjunctivitis, alopecia, amyloidosis, angioedema, anterior segment inflammation, autoimmune hepatitis, Behcet's syndrome, berylliosis, contraceptive, bone pain, bursitis, carpal tunnel syndrome, chorioretinitis, chronic lymphocytic leukemia, corneal ulcer, diffuse intrinsic pontine glioma, epicondylitis, erythroblastopenia, gout, gouty arthritis, graft-versus-host disease, heart failure, hemolytic anemia, Hodgkin's disease, hypercalcemia, hyperammonemia, hypoplastic anemia, idiopathic thrombocytopenic purpura, iritis, juvenile rheumatoid arthritis, keratitis, kidney transplant rejection prophylaxis, Loeffler's syndrome, mixed connective tissue disease, myasthenia gravis, mycosis fungiodes, optic neuritis, pemphigus, pneumonia, pneumonitis, polychondritis, psoriasis, rheumatic carditis, severe pain, sickle cell, sickle cell anemia, Stevens-Johnson syndrome, temporal arteritis, tenosynovitis, thyroiditis, urticarial, Wegener's granulomatosis, and weight loss, comprising the administration, to a patient in need thereof, of a therapeutically effective amount of a compound chosen from the group consisting of:
地址 Rockville MD US